Business Description
Coherus BioSciences Inc
NAICS : 541714
SIC : 2836
ISIN : US19249H1032
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | -0.31 | |||||
Debt-to-Equity | -2.49 | |||||
Debt-to-EBITDA | -2.48 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -3.7 | |||||
Beneish M-Score | -1.43 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -21.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.81 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.59 | |||||
9-Day RSI | 32.6 | |||||
14-Day RSI | 39.41 | |||||
6-1 Month Momentum % | -41.65 | |||||
12-1 Month Momentum % | -72.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.43 | |||||
Quick Ratio | 1.24 | |||||
Cash Ratio | 0.35 | |||||
Days Inventory | 129.28 | |||||
Days Sales Outstanding | 235.47 | |||||
Days Payable | 62.6 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.7 | |||||
Shareholder Yield % | -42.1 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 38.19 | |||||
Operating Margin % | -78.99 | |||||
Net Margin % | -92.48 | |||||
FCF Margin % | -68.46 | |||||
ROA % | -46.35 | |||||
ROIC % | -105.82 | |||||
ROC (Joel Greenblatt) % | -290.12 | |||||
ROCE % | -63.24 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.75 | |||||
EV-to-EBIT | -2.98 | |||||
EV-to-Forward-EBIT | -16.32 | |||||
EV-to-EBITDA | -3.04 | |||||
EV-to-Forward-EBITDA | -17.14 | |||||
EV-to-Revenue | 2.29 | |||||
EV-to-Forward-Revenue | 2.44 | |||||
EV-to-FCF | -3.37 | |||||
Earnings Yield (Greenblatt) % | -33.56 | |||||
FCF Yield % | -77.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Coherus BioSciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 238.288 | ||
EPS (TTM) (€) | -2.412 | ||
Beta | 0 | ||
Volatility % | 92.09 | ||
14-Day RSI | 39.41 | ||
14-Day ATR (€) | 0.057516 | ||
20-Day SMA (€) | 2.152275 | ||
12-1 Month Momentum % | -72.91 | ||
52-Week Range (€) | 1.43 - 7.48 | ||
Shares Outstanding (Mil) | 113.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Coherus BioSciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Coherus BioSciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Coherus BioSciences Inc Frequently Asked Questions
What is Coherus BioSciences Inc(FRA:8C5)'s stock price today?
When is next earnings date of Coherus BioSciences Inc(FRA:8C5)?
Does Coherus BioSciences Inc(FRA:8C5) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |